{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T09:29:20Z","timestamp":1772357360898,"version":"3.50.1"},"reference-count":11,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.3892\/mco.2014.422","type":"journal-article","created":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T10:57:33Z","timestamp":1411124253000},"page":"249-251","source":"Crossref","is-referenced-by-count":12,"title":["Bacillus Calmette-Gu\u00e9rin therapy-associated granulomatous prostatitis mimicking prostate cancer on MRI: A case report and literature review"],"prefix":"10.3892","volume":"3","author":[{"given":"NICOLAIE","family":"SUDITU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DRAGOS","family":"NEGRU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,9,19]]},"reference":[{"key":"key20180107145357_b1-mco-03-01-0249","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2013.06.003","article-title":"European Association of Urology: EAU guidelines of non-muscle-invasive urothelial carcinoma of the bladder: update 2013","volume":"64","author":"Babjuk","year":"2013","journal-title":"Eur Urol"},{"key":"key20180107145357_b2-mco-03-01-0249","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus Calmette-Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"key20180107145357_b3-mco-03-01-0249","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.eururo.2010.10.039","article-title":"European Association of Urology: EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease","volume":"59","author":"Heidenreich","year":"2011","journal-title":"Eur Urol"},{"key":"key20180107145357_b4-mco-03-01-0249","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0022-5347(17)45606-0","article-title":"Complications of bacillus Calmette-Gu\u00e9rin immunotherapy in 1,278 patients with bladder cancer","volume":"135","author":"Lamm","year":"1986","journal-title":"J Urol"},{"key":"key20180107145357_b5-mco-03-01-0249","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0090-4295(96)00507-9","article-title":"Incidence of granulomatous prostatitis and acid-fast bacilli after intravesical BCG therapy","volume":"49","author":"LaFontaine","year":"1997","journal-title":"Urology"},{"key":"key20180107145357_b6-mco-03-01-0249","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0022-5347(17)41803-9","article-title":"Granulomatous prostatitis following bacillus Calmette-Gu\u00e9rin immunotherapy of bladder cancer","volume":"140","author":"Oates","year":"1988","journal-title":"J Urol"},{"key":"key20180107145357_b7-mco-03-01-0249","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0022-5347(17)37316-0","article-title":"Incidence and treatment of complication of bacillus Calmette-Gu\u00e9rin intravesical therapy in superficial bladder cancer","volume":"147","author":"Lamm","year":"1992","journal-title":"J Urol"},{"key":"key20180107145357_b8-mco-03-01-0249","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0022-5347(05)67025-5","article-title":"Elevated prostate specific antigen serum levels after intravesical instillation of bacillus Calmette-Gu\u00e9rin","volume":"164","author":"Leibovici","year":"2000","journal-title":"J Urol"},{"key":"key20180107145357_b9-mco-03-01-0249","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.2214\/AJR.08.1962","article-title":"Imaging appearance of granulomatous disease after intravesical Bacille Calmette-Gu\u00e9rin (BCG) treatment of bladder carcinoma","volume":"192","author":"Ma","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"key20180107145357_b10-mco-03-01-0249","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.eursup.2008.08.001","article-title":"Clinical practice recommendations for the prevention and management of intravesical therapy-associated adverse events","author":"Witjes","year":"2008","journal-title":"Eur Urol"},{"key":"key20180107145357_b11-mco-03-01-0249","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","article-title":"European Society of Urogenital Radiology: ESUR prostate MR guidelines 2012","volume":"22","author":"Barentsz","year":"2012","journal-title":"Eur Radiol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2014.422\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T14:54:06Z","timestamp":1515336846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2014.422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,19]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,9,19]]},"published-print":{"date-parts":[[2015,1]]}},"alternative-id":["10.3892\/mco.2014.422"],"URL":"https:\/\/doi.org\/10.3892\/mco.2014.422","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,19]]}}}